@article{1a1b2a92602648afacbc801c497b35ef,
title = "Phenytoin in acute optic neuritis: neuroprotective or not?",
author = "Shiv Saidha and Calabresi, {Peter A.}",
note = "Funding Information: SS receives funding support from the Race to Erase MS and Genentech, has received consulting fees from Medical Logix for the development of continuing medical education programmes in neurology, consulting fees from Axon Advisors LLC, educational grant support from Novartis and Teva Neurosciences, speaking honoraria from the National Association of Managed Care Physicians, Advanced Studies in Medicine, and the Family Medicine Foundation of West Virginia, and served on scientific advisory boards for Biogen-Idec and Genzyme. PAC has received personal compensation for consulting and serving on scientific advisory boards from Vertex, Vaccinex, Merck, and Prothena, and has received research funding from Biogen-IDEC, MedImmune, and Novartis. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",
year = "2016",
doi = "10.1016/S1474-4422(16)00024-7",
language = "English (US)",
volume = "15",
pages = "233--235",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "3",
}